UniProt ID | FGFR1_MOUSE | |
---|---|---|
UniProt AC | P16092 | |
Protein Name | Fibroblast growth factor receptor 1 | |
Gene Name | Fgfr1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 822 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. Nucleus. Cytoplasm, cytosol. Cytoplasmic vesicle. After ligand binding, both receptor and ligand are rapidly internalized. Can translocate to the nucleus after internalization, or by translocation f |
|
Protein Description | Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation (By similarity).. | |
Protein Sequence | MWGWKCLLFWAVLVTATLCTARPAPTLPEQAQPWGVPVEVESLLVHPGDLLQLRCRLRDDVQSINWLRDGVQLVESNRTRITGEEVEVRDSIPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRRPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMLGSVIIYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSIPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPTQLANSGLKRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
76 | Phosphorylation | DGVQLVESNRTRITG HCEEEEECCCCEECC | 24.92 | - | |
77 | N-linked_Glycosylation | GVQLVESNRTRITGE CEEEEECCCCEECCC | 35.52 | - | |
117 | N-linked_Glycosylation | DTTYFSVNVSDALPS CCEEEEEEHHHCCCC | 26.78 | - | |
180 | Phosphorylation | TVKFKCPSSGTPNPT EEEEECCCCCCCCCC | 51.36 | - | |
198 (in isoform 3) | Ubiquitination | - | 51.10 | 22790023 | |
198 | Ubiquitination | LKNGKEFKPDHRIGG HHCCCCCCCCCCCCC | 51.10 | 22790023 | |
208 (in isoform 3) | Ubiquitination | - | 4.21 | - | |
227 | N-linked_Glycosylation | VVPSDKGNYTCIVEN CCCCCCCCEEEEEEC | 34.38 | - | |
240 | N-linked_Glycosylation | ENEYGSINHTYQLDV ECCCCCEEEEEEEEE | 24.12 | - | |
264 | N-linked_Glycosylation | LQAGLPANKTVALGS CCCCCCCCCEEECCC | 38.29 | - | |
296 | N-linked_Glycosylation | WLKHIEVNGSKIGPD EEEEEEECCCCCCCC | 35.91 | - | |
317 | N-linked_Glycosylation | ILKTAGVNTTDKEME EEECCCCCCCCCCEE | 36.02 | 19349973 | |
330 | N-linked_Glycosylation | MEVLHLRNVSFEDAG EEEEEECCCCHHHCC | 39.90 | - | |
410 | Phosphorylation | TKKSDFHSQMAVHKL CCCHHHHHHHHHHHH | 22.96 | 25338131 | |
447 | Phosphorylation | GVLLVRPSRLSSSGT CEEEEEHHHCCCCCC | 34.98 | 25338131 | |
450 | Phosphorylation | LVRPSRLSSSGTPML EEEHHHCCCCCCCCC | 22.73 | 26370283 | |
451 | Phosphorylation | VRPSRLSSSGTPMLA EEHHHCCCCCCCCCC | 37.06 | 26370283 | |
452 | Phosphorylation | RPSRLSSSGTPMLAG EHHHCCCCCCCCCCC | 43.22 | 25338131 | |
454 | Phosphorylation | SRLSSSGTPMLAGVS HHCCCCCCCCCCCCC | 13.89 | 25338131 | |
463 | Phosphorylation | MLAGVSEYELPEDPR CCCCCCCCCCCCCCC | 18.43 | - | |
583 | Phosphorylation | RRPPGLEYCYNPSHN HCCCCCCCCCCCCCC | 12.79 | 27717184 | |
585 | Phosphorylation | PPGLEYCYNPSHNPE CCCCCCCCCCCCCHH | 29.25 | 27717184 | |
605 | Phosphorylation | KDLVSCAYQVARGME HHHHHHHHHHHHHHH | 14.09 | - | |
613 | Phosphorylation | QVARGMEYLASKKCI HHHHHHHHHHCCCCC | 9.93 | - | |
653 | Phosphorylation | RDIHHIDYYKKTTNG CCCCCCEEEECCCCC | 19.31 | 26824392 | |
654 | Phosphorylation | DIHHIDYYKKTTNGR CCCCCEEEECCCCCC | 11.40 | 20116462 | |
730 | Phosphorylation | SNCTNELYMMMRDCW CCCHHHHHHHHHHHH | 4.10 | - | |
766 | Phosphorylation | ALTSNQEYLDLSIPL HCCCCCCEECEECCH | 8.85 | 12181353 | |
777 | Phosphorylation | SIPLDQYSPSFPDTR ECCHHHCCCCCCCCC | 14.40 | 25338131 | |
785 | Phosphorylation | PSFPDTRSSTCSSGE CCCCCCCCCCCCCCC | 31.90 | 26160508 | |
786 | Phosphorylation | SFPDTRSSTCSSGED CCCCCCCCCCCCCCC | 30.09 | 25293948 | |
787 | Phosphorylation | FPDTRSSTCSSGEDS CCCCCCCCCCCCCCC | 20.04 | 26160508 | |
789 | Phosphorylation | DTRSSTCSSGEDSVF CCCCCCCCCCCCCCC | 41.27 | 26160508 | |
790 | Phosphorylation | TRSSTCSSGEDSVFS CCCCCCCCCCCCCCC | 48.63 | 26160508 | |
794 | Phosphorylation | TCSSGEDSVFSHEPL CCCCCCCCCCCCCCC | 22.28 | 26160508 | |
817 | Phosphorylation | HPTQLANSGLKRR-- CHHHHHHCCCCCC-- | 39.64 | 28066266 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FGFR1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FGFR1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FRS2_MOUSE | Frs2 | physical | 15513912 | |
VIGLN_HUMAN | HDLBP | physical | 26496610 | |
MAP2_HUMAN | METAP2 | physical | 26496610 | |
HOMEZ_HUMAN | HOMEZ | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-317, AND MASSSPECTROMETRY. |